Abstract
We evaluated the 12 month growth of 18 pubertal children with familial short stature randomly assigned to clinical follow-up (group A), GH treatment alone (group B) and GH+LHRH analogue (LHRHa) treatment (group C). Height velocity increased significantly compared to baseline in groups A and B (4.7±0.4 vs 6.6±0.6 and 4.4±0.3 vs 8±1 respectively), but not in C (5±0.5 vs 6.5±0.4). Moreover in group B height and height prognosis standard deviation score SDS) also were higher (−2.2±0.2 vs−1.7±0.2 and 1.8±0.3 vs −1±0.2, respectively). Comparisons among the groups showed a significant increase in group B vs the other groups of height velocity SDS (3.9±1.3 vs 0.4+1 and 0.3±0.7) and of height prognosis SDS (−1±0.2 vs −2.4±0.3 and −2.4±0.3). In conclusion, after one-year treatment, GH seems to be more effective in stimulating growth than GH±LHRHa, even if studies of longer duration and/or follow-up are needed.
Similar content being viewed by others
References
Frasier S.D., Lippe B.M. Clinical review 11: the rational use of growth hormone during childhood. J. Clin. Endocrinol. Metab. 71: 269, 1990.
Moore W.V., Moore K.C., Gifford R., Hollowell J.G., Donaldson D.L. Long-term treatment with growthr hormone of children with short stature and normal growth hormone secretion. J. Pediatr. 120: 702, 1992.
Hindmarsh P.C., Pringle P.J., DeSilvo L., Brook C.G.D. Effect of 3 years of growth hormone therapy in short normal children. Acta Pediatr. Scand. (Suppl.) 366: 6, 1990.
Volta C., Ghizzoni L., Muto G., Spaggiari R., Virdis R., Bernasconi S. Effectiveness of growth-promoting therapies: Comparison among growth hormone, clonidine, and L-Dopa. A.J.D.C. 145: 168, 1991.
Colle M., Sagnard L., Ducret J.P., Auzerie J. Growth response to growth-hormone administration during the decelerating phase of the pubertal growth spurt in short normal children. Horm. Res. 34: 204, 1990.
Bourguigon J.P., Vanderweghe M., Vanderschueren-Lodeweyck M., Malvaux P., Wolter R., Du Caju M., Ernould C. Pubertal growth and final height in hypopituitary boys: a minor role of bone age at onset of puberty. J. Clin. Endocrinol. Metab. 63: 376, 1986.
Toublanc J.E., Couprie C., Gamier P., Job J.C. The effects of treatment combining an antagonist of gonadotropin-releasing hormone with growth hormone in pubertal patients with isolated growth hormone deficiency. Acta Endocrinol. (Copenh.) 120: 795, 1989.
Darendeliler F., Hindmarsh P.C., Brook C.D.G. Non-conventional use of growth hormone: European experience. Horm. Res. 33: 128, 1990.
Greulich W.W., Pyle S.J. Radiographic atlas of skeletal development of the hand and the wrist, ed.2. Calif. Stanford University Press, Stanford CA, 1959.
Tanner J.M., Whitehouse R.H., Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children 1965. Arch. Dis. Child 41: 613, 1966.
Bernasconi S., Vanelli M., Nori G., et al. Serum TSH, T4, T3, FT4, FT3, rT3 and TBG in youngsters with non ketotic insulin dependent diabetes mellitus. Horm. Res. 20: 213, 1984.
Polychronakos C, Abu-Srair H., Guyda H.J. Transient growth deceleration in normal short children. A potential bias in growth studies. Eur. J. Pediatr. 147: 582, 1988.
Darendeliler F., Hindmarsh P.C., Preece M.A., Cox L, Brook C.G.D. Growth hormone increases rate of pubertal maturation. Acta Endocrinol. (Copenh.) 122: 414, 1990.
Davoren J.B., Hsueh J.W. Growth hormone increases ovarian levels of immunoreactive somatomedin C/insulin-like growth factor in vivo. Endocrinology 118: 888, 1986.
Trees L.L., Smith E., Van Wyk J., Kierszenbaum A.L. Somatomedin C in rat Sertoli-spermatogenic cell co-cultures. J. Cell. Biol. 97: 18a, 1983 (Abstract).
Conn P.M., Crowley W.F. Gonadotropin-releasing hormone and its analogue. N. Engl. J. Med. 324: 93, 1991.
Kauli R., Kornreich L, Laron Z. Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-Trp-6-LHRH. Horm. Res. 33: 11, 1990.
Oerter K.E., Manasco P., Barnes K.M., Jones J., Hill S., Cutler J.B. Jr. Adult height in precocious puberty after long-term treatment with deslorelin. J. Clin. Endocrinol. Metab. 73: 1235, 1991.
Chaussain J.L., Swaenepoel C, Roger M. Traitment des pubertés precoces par une forme a liberation prolongee d’un analogue du LHRH (D-TRP6-LHRH). In: Chaussain J.L., Roger M. (Eds), Puberté et croissance pubertaire. Ed SEPE, Paris, 1991, p. 137.
Lindner D., Job J.C, Chaussain J.L. Failure to improve height prediction in short stature pubertal adolescents by inhibiting puberty with LHRH analog. Eur. J. Pediatr. (in press).
Job J.C., Landier F., Chaussain J.L., Toublanc J.E. Essai de traitement par hormone de croissance seule ou associée à un analogue de LHRH chez les adolescents de petite taille, en cours de puberté. In: Chaussain J.L., Roger M. (Eds.), Puberté et croissance pubertaire. Ed SEPE Paris, 1991, p. 49.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Volta, C., Bernasconi, S., Tondi, P. et al. Combined treatment with growth hormone and luteinizing hormone releasing hormone-analogue (LHRHa) of pubertal children with familial short stature. J Endocrinol Invest 16, 763–767 (1993). https://doi.org/10.1007/BF03348921
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348921